Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KAYLA SHERMAN

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1063169480
CMS profile
11310754
Location
GAYLORD, MI

General Payments · PY2022–2024

$1,554.50

  • Reported across 82 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$690.31

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $690.31 34

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $201.90 11
Xeris Pharmaceuticals, Inc. $129.26 6
ABBVIE INC. $97.41 5
Exact Sciences Corporation $66.22 3
Grifols USA, LLC $61.28 3
ITI, Inc. $49.12 2
Takeda Pharmaceuticals U.S.A., Inc. $25.36 1
Antares Pharma, Inc. $21.53 1
DEXCOM, INC. $19.17 1
Lilly USA, LLC $19.06 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $370.83 21
PY2023 $493.36 27
PY2024 $690.31 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $23.38 01/08/2024 Food and Beverage Undisputed 01/23/2026 1108188194 CMS
ABBVIE INC. $17.85 01/19/2024 Food and Beverage Undisputed 01/23/2026 1108188196 CMS
ABBVIE INC. $18.01 07/11/2024 Food and Beverage Undisputed 01/23/2026 1108188198 CMS
ABBVIE INC. $17.36 09/10/2024 Food and Beverage Undisputed 01/23/2026 1108188200 CMS
ABBVIE INC. $20.81 12/13/2024 Food and Beverage Undisputed 01/23/2026 1108188202 CMS
Antares Pharma, Inc. $21.53 07/12/2024 Food and Beverage Undisputed 01/23/2026 1146522725 CMS
AstraZeneca Pharmaceuticals LP $17.02 01/18/2024 Food and Beverage Undisputed 01/23/2026 1105224502 CMS
AstraZeneca Pharmaceuticals LP $23.40 01/22/2024 Food and Beverage Undisputed 01/23/2026 1104231161 CMS
AstraZeneca Pharmaceuticals LP $24.73 01/22/2024 Food and Beverage Undisputed 01/23/2026 1105807022 CMS
AstraZeneca Pharmaceuticals LP $17.95 02/05/2024 Food and Beverage Undisputed 01/23/2026 1105606285 CMS
AstraZeneca Pharmaceuticals LP $15.30 03/04/2024 Food and Beverage Undisputed 01/23/2026 1105753731 CMS
AstraZeneca Pharmaceuticals LP $18.67 03/12/2024 Food and Beverage Undisputed 01/23/2026 1105575994 CMS
AstraZeneca Pharmaceuticals LP $13.87 04/29/2024 Food and Beverage Undisputed 01/23/2026 1105607795 CMS
AstraZeneca Pharmaceuticals LP $14.31 05/14/2024 Food and Beverage Undisputed 01/23/2026 1104644703 CMS
AstraZeneca Pharmaceuticals LP $18.97 08/26/2024 Food and Beverage Undisputed 01/23/2026 1104254099 CMS
AstraZeneca Pharmaceuticals LP $17.60 09/26/2024 Food and Beverage Undisputed 01/23/2026 1104635319 CMS
AstraZeneca Pharmaceuticals LP $20.08 10/14/2024 Food and Beverage Undisputed 01/23/2026 1105524205 CMS
Dexcom, Inc. $19.17 02/23/2024 Food and Beverage Undisputed 01/23/2026 1153370711 CMS
Exact Sciences Corporation $18.95 03/18/2024 Food and Beverage Undisputed 01/23/2026 1114894598 CMS
Exact Sciences Corporation $20.70 06/20/2024 Food and Beverage Undisputed 01/23/2026 1114894604 CMS
Exact Sciences Corporation $26.57 09/17/2024 Food and Beverage Undisputed 01/23/2026 1114894615 CMS
Grifols USA, LLC $20.48 01/11/2024 Food and Beverage Undisputed 01/23/2026 1124716634 CMS
Grifols USA, LLC $17.88 02/15/2024 Food and Beverage Undisputed 01/23/2026 1124716636 CMS
Grifols USA, LLC $22.92 10/10/2024 Food and Beverage Undisputed 01/23/2026 1124716632 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.27 10/22/2024 Food and Beverage Undisputed 01/23/2026 1143603160 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.85 11/19/2024 Food and Beverage Undisputed 01/23/2026 1143603162 CMS
Lilly USA, LLC $19.06 05/20/2024 Food and Beverage Undisputed 01/23/2026 1135766389 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.36 11/18/2024 Food and Beverage Undisputed 01/23/2026 1137823344 CMS
Xeris Pharmaceuticals, Inc. $21.30 01/16/2024 Food and Beverage Undisputed 01/23/2026 1144631021 CMS
Xeris Pharmaceuticals, Inc. $24.42 02/20/2024 Food and Beverage Undisputed 01/23/2026 1144631027 CMS
Xeris Pharmaceuticals, Inc. $15.39 05/16/2024 Food and Beverage Undisputed 01/23/2026 1144631029 CMS
Xeris Pharmaceuticals, Inc. $21.06 09/03/2024 Food and Beverage Undisputed 01/23/2026 1144631023 CMS
Xeris Pharmaceuticals, Inc. $23.20 11/12/2024 Food and Beverage Undisputed 01/23/2026 1144631025 CMS
Xeris Pharmaceuticals, Inc. $23.89 12/03/2024 Food and Beverage Undisputed 01/23/2026 1144631031 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.